Treating the ovalbumin-sensitized murine models of AD with this complex significantly reduced the IL-13 production (by as much as 70% of the control) in the suffering skin regions as well as the IL-4 and IL-5 levels, alongside decreased inflammatory cell infiltration and skin thickness.174. The gene discussed is IL13; the disease is Alzheimer disease.